Skip to main content
. 2020 May 13;29(10):2651–2660. doi: 10.1007/s11136-020-02520-7

Fig. 5.

Fig. 5

Unadjusted Mean (95% CI) Change from Baseline for EORTC QLQ-30 Functional Scales, Global Health Status/QoL (a) and Symptom Scores (b), and EQ-VAS (c) at Week 24. For global health status/quality of life score and all functional scales, a higher score denotes better quality of life or function. For symptom scores, a lower score denotes fewer symptoms. For the EQ-VAS, higher score denotes better quality of life. VAS Visual analog scale, PEMBRO pembrolizumab, IPI + NIVO ipilimumab + nivolumab,